Physician

Eric J Kahle, M.D.

According to 2025 Medicare claims, Eric Kahle, M.D. (NPI: 1578541900) practices ophthalmology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is EYE ASSOCIATES OF SEBASTOPOL MEDICAL GROUP INC (NPI: 1295729382; TIN: 680413229) and primary practice location at 95472-4270.

Kahle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 938 traditional Medicare patients, billed 14,558 HCPCS/CPT codes, and received $1,055,657 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,408 prescription claims across 561 beneficiaries totaling $135,178 in drug costs, led by Restasis (Cyclosporine). DME data shows 112 claims. Open Payments data shows 7 records totaling $150. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,017	10,031	$1,076,015
2016	1,623	9,180	$1,110,926
2017	1,296	8,484	$1,072,718
2018	1,131	7,782	$1,093,600
2019	1,123	6,797	$986,597
2020	922	6,711	$862,348
2021	1,015	7,269	$971,628
2022	1,248	8,095	$1,084,312
2023	1,472	13,080	$1,169,163
2024	938	14,558	$1,055,657

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	470	2,472	$127,477
2016	517	2,663	$141,957
2017	527	2,590	$146,789
2018	511	2,495	$130,819
2019	541	2,435	$148,195
2020	430	2,118	$274,243
2021	520	2,399	$198,535
2022	565	2,717	$171,768
2023	620	2,680	$182,519
2024	561	2,408	$135,178

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	109	118	$8,294
2016	89	93	$5,877
2017	66	74	$4,634
2018	45	46	$2,965
2019	54	61	$4,018
2020	36	41	$3,474
2021	56	60	$4,502
2022	13	14	$837
2023	95	122	$8,410
2024	99	112	$7,870

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	391	650	$94
92014	Established patient complete exam of visual system	402	788	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	304	329	$69
92134	Imaging of retina	327	687	$32
92136	Measurement of corneal curvature and depth of eye	266	398	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	36	1,560	$28,026
Prednisolone Acetate	Prednisolone Acetate	413	14,801	$19,882
Rocklatan	Netarsudil Mesylat/Latanoprost	15	884	$11,448
Vyzulta	Latanoprostene Bunod	25	1,085	$11,393
Simbrinza	Brinzolamide/Brimonidine Tart	38	1,537	$9,091

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	32	37	$2,697
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	13	15	$1,628
V2200	Sphere, bifocal, plano to plus or minus 4.00d, per lens	N	12	12	$1,177
V2103	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	17	20	$1,065
V2100	Sphere, single vision, plano to plus or minus 4.00, per lens	N	14	16	$936

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$150	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eric J. Kahle, M.D.?

Tedicare shows public-source Medicare data for Eric J. Kahle, M.D. (NPI 1578541900), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric J. Kahle, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Eric J. Kahle, M.D.?

Eric J. Kahle, M.D. is linked to EYE ASSOCIATES OF SEBASTOPOL MEDICAL GROUP INC (billing NPI 1295729382) in the available physician profile data.

Does Eric J. Kahle, M.D. have Open Payments data?

Eric J. Kahle, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.